Business
Investor Day
Investor Day.

About this update from Inspiration Healthcare Group Plc
[{"type":"text","content":"\n\n 4 May 2023\nInspiration Healthcare Group plc\n(\"Inspiration Healthcare\", the \"Company\" or the \"Group\")\n \nInvestor Day\n \nInspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that it will hold an Open Day for investors at the Company's headquarters in Croydon, South London on Wednesday, 7 June 2023 from 10am to 1pm. The day is open to all existing and potential investors, and to anyone who wishes to meet the Company and hear the story.\n \nManagement will also present an update on trading for the year ended 31 January 2023 following the release of the Company's Preliminary Results on 3 May 2023.\n \nThe day will provide an opportunity for investors to meet the Senior Management team, take a tour of the facility and familiarise themselves with the Company's products. This will be followed by a light lunch.\n \nIf you wish to attend, please register through Walbrook PR to reserve a space, which are limited. This can be done either by emailing [email protected] or calling Walbrook PR on the number below.\n \n \nFor further information:\n\n\n\nInspiration Healthcare Group plc\n\n\nTel: +44 (0)330 175 0000\n \n\n\n\n\nNeil Campbell, Chief Executive Officer\n\n\n\n\n\n\n\nPaul Bergin, Interim Chief Financial Officer\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\nCenkos Securities plc (Nominated Adviser & Broker)\n\n\nTel: +44 (0)207 397 8900\n\n\n\n\nStephen Keys, Katy Birkin, Dan Hodkinson\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Ltd (Media and Investor Relations)\n\n\nTel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\nAnna Dunphy\n\n\nMob: +44 (0) 7876 741 001\n\n\n\n\nStephanie Cuthbert\n\n\nMob: +44 (0) 7796 794 663\n\n\n\n\n\n\n\n\n \nAbout Inspiration Healthcare\n \nInspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.\n \nThe Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabil...